TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smokerface: A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools: Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether photoaging mobile app promoting poster campaigns are effective to reduce smoking prevalence among adolescents in Germany. This is measured via questionnaire.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Photoaging mobile app promoting poster campaign. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Photoaging mobile app promoting poster campaign.; Assigned to Arm(s): Intervention
B: Intervention Type: BEHAVIORAL; Name: Pediatric Practice-Based Smoking Intervention; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): N/A
D: Arm Label: Ritalin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ritalin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ritalin; Assigned to Arm(s): Ritalin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smokerface: A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools: Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether photoaging mobile app promoting poster campaigns are effective to reduce smoking prevalence among adolescents in Germany. This is measured via questionnaire.


Options:
A: Arm Label: Control group; Type: OTHER; Interventions: Other: Control group | Arm Label: Cell phone Aplication for Smarth Phone; Type: ACTIVE_COMPARATOR; Interventions: Device: Cell phone Aplication for Smarth Phone | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group | Intervention Type: DEVICE; Name: Cell phone Aplication for Smarth Phone; Assigned to Arm(s): Cell phone Aplication for Smarth Phone
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Photoaging mobile app promoting poster campaign. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Photoaging mobile app promoting poster campaign.; Assigned to Arm(s): Intervention
C: Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: transdermal nicotine, Behavioral: Telephone counseling | Arm Label: Contingency management for abstinence from cigarettes; Type: EXPERIMENTAL; Interventions: Behavioral: contingency management for smoking abstinence, Drug: transdermal nicotine, Behavioral: Telephone counseling | Intervention Type: BEHAVIORAL; Name: contingency management for smoking abstinence; Assigned to Arm(s): Contingency management for abstinence from cigarettes | Intervention Type: DRUG; Name: transdermal nicotine; Assigned to Arm(s): Contingency management for abstinence from cigarettes, Standard Care | Intervention Type: BEHAVIORAL; Name: Telephone counseling; Assigned to Arm(s): Contingency management for abstinence from cigarettes, Standard Care
D: Arm Label: UC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: WEB+TXT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WEB+TXT | Arm Label: WEB+TXT+TTS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WEB+TXT+TTS | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): UC | Intervention Type: BEHAVIORAL; Name: WEB+TXT; Assigned to Arm(s): WEB+TXT | Intervention Type: BEHAVIORAL; Name: WEB+TXT+TTS; Assigned to Arm(s): WEB+TXT+TTS

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High-flow Nasal Cannula Oxygen Versus Conventional Oxygen Therapy After Pulmonary Lobectomy
Brief Summary: The primary objective of this study is to evaluate the effect of early application of nasal high flow oxygen therapy after pulmonary lobectomy on the incidence of postoperative hypoxemia


Options:
A: Arm Label: High Flow Conditioned Oxygen Therapy in high risk patients; Type: EXPERIMENTAL; Interventions: Device: High Flow Conditioned Oxygen Therapy in High Risk Patients | Arm Label: Non-invasive mechanical ventilation in High Risk Patients; Type: ACTIVE_COMPARATOR; Interventions: Device: Non-invasive mechanical ventilation | Arm Label: High Flow Conditioned Oxygen Therapy in Low Risk Patients; Type: EXPERIMENTAL; Interventions: Device: High Flow Conditioned Oxygen Therapy in High Risk Patients | Arm Label: Conventional Oxygen Therapy in Low Risk Patients; Type: ACTIVE_COMPARATOR; Interventions: Device: Conventional Oxygen Therapy | Intervention Type: DEVICE; Name: High Flow Conditioned Oxygen Therapy in High Risk Patients; Assigned to Arm(s): High Flow Conditioned Oxygen Therapy in Low Risk Patients, High Flow Conditioned Oxygen Therapy in high risk patients | Intervention Type: DEVICE; Name: Non-invasive mechanical ventilation; Assigned to Arm(s): Non-invasive mechanical ventilation in High Risk Patients | Intervention Type: DEVICE; Name: Conventional Oxygen Therapy; Assigned to Arm(s): Conventional Oxygen Therapy in Low Risk Patients
B: Arm Label: HFNT; Type: EXPERIMENTAL; Interventions: Other: HFNT | Arm Label: NIV; Type: ACTIVE_COMPARATOR; Interventions: Other: NIV | Intervention Type: OTHER; Name: HFNT; Assigned to Arm(s): HFNT | Intervention Type: OTHER; Name: NIV; Assigned to Arm(s): NIV
C: Arm Label: BIPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: Non invasive ventilation (VNI) | Arm Label: OPTIFLOW; Type: EXPERIMENTAL; Interventions: Device: Non invasive ventilation | Intervention Type: DEVICE; Name: Non invasive ventilation (VNI); Assigned to Arm(s): BIPAP | Intervention Type: DEVICE; Name: Non invasive ventilation; Assigned to Arm(s): OPTIFLOW
D: Arm Label: High-flow nasal cannula oxygen (HFNCO); Type: EXPERIMENTAL; Interventions: Device: High-flow Nasal Cannula Oxygen (HFNCO) | Arm Label: standard oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Conventional oxygen treatment | Intervention Type: DEVICE; Name: High-flow Nasal Cannula Oxygen (HFNCO); Assigned to Arm(s): High-flow nasal cannula oxygen (HFNCO) | Intervention Type: DEVICE; Name: Conventional oxygen treatment; Assigned to Arm(s): standard oxygen therapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High-flow Nasal Cannula Oxygen Versus Conventional Oxygen Therapy After Pulmonary Lobectomy
Brief Summary: The primary objective of this study is to evaluate the effect of early application of nasal high flow oxygen therapy after pulmonary lobectomy on the incidence of postoperative hypoxemia


Options:
A: Arm Label: CF patients HFN; Type: EXPERIMENTAL; Interventions: Device: High flow nasal oxygen cannula | Arm Label: CF patients NIV; Type: EXPERIMENTAL; Interventions: Device: Noninvasive ventilation | Intervention Type: DEVICE; Name: High flow nasal oxygen cannula; Assigned to Arm(s): CF patients HFN | Intervention Type: DEVICE; Name: Noninvasive ventilation; Assigned to Arm(s): CF patients NIV
B: Arm Label: High-flow nasal cannula oxygen (HFNCO); Type: EXPERIMENTAL; Interventions: Device: High-flow Nasal Cannula Oxygen (HFNCO) | Arm Label: standard oxygen therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Conventional oxygen treatment | Intervention Type: DEVICE; Name: High-flow Nasal Cannula Oxygen (HFNCO); Assigned to Arm(s): High-flow nasal cannula oxygen (HFNCO) | Intervention Type: DEVICE; Name: Conventional oxygen treatment; Assigned to Arm(s): standard oxygen therapy
C: Arm Label: Optiflow then CPAP; Type: EXPERIMENTAL; Interventions: Procedure: O2stand, Procedure: CPAP, Procedure: Optiflow | Arm Label: CPAP then Optiflow; Type: EXPERIMENTAL; Interventions: Procedure: O2stand, Procedure: CPAP, Procedure: Optiflow | Intervention Type: PROCEDURE; Name: O2stand; Assigned to Arm(s): CPAP then Optiflow, Optiflow then CPAP | Intervention Type: PROCEDURE; Name: CPAP; Assigned to Arm(s): CPAP then Optiflow, Optiflow then CPAP | Intervention Type: PROCEDURE; Name: Optiflow; Assigned to Arm(s): CPAP then Optiflow, Optiflow then CPAP
D: Arm Label: Venturi mask; Type: ACTIVE_COMPARATOR; Interventions: Device: Venturi mask | Arm Label: Nasal high-flow; Type: ACTIVE_COMPARATOR; Interventions: Device: Nasal high-flow | Intervention Type: DEVICE; Name: Venturi mask; Assigned to Arm(s): Venturi mask | Intervention Type: DEVICE; Name: Nasal high-flow; Assigned to Arm(s): Nasal high-flow

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Study of Extra-Corporal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction
Brief Summary: This study compares standard treatment plus Extra-Corporal Life Support (ECLS) versus standard treatment alone in patients with cardiogenic shock due to myocardial infarction.


Options:
A: Arm Label: ECMO Facilitated Resuscitation; Type: EXPERIMENTAL; Interventions: Device: Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation | Arm Label: Standard ACLS Resuscitation; Type: OTHER; Interventions: Device: Standard Advanced Cardiac Life Support (ACLS) Resuscitation | Intervention Type: DEVICE; Name: Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation; Assigned to Arm(s): ECMO Facilitated Resuscitation | Intervention Type: DEVICE; Name: Standard Advanced Cardiac Life Support (ACLS) Resuscitation; Assigned to Arm(s): Standard ACLS Resuscitation
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: lung protective ventilation | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: lung protective ventilation | Intervention Type: OTHER; Name: lung protective ventilation; Assigned to Arm(s): 1, 2
C: Arm Label: Extra-Corporal Life Support (ECLS); Type: ACTIVE_COMPARATOR; Interventions: Device: Extra-Corporal Life Support (ECLS) | Arm Label: Standard treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Extra-Corporal Life Support (ECLS); Assigned to Arm(s): Extra-Corporal Life Support (ECLS)
D: Arm Label: Intensive care survivors; Type: N/A; Interventions: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Study of Extra-Corporal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction
Brief Summary: This study compares standard treatment plus Extra-Corporal Life Support (ECLS) versus standard treatment alone in patients with cardiogenic shock due to myocardial infarction.


Options:
A: Arm Label: Extra-Corporal Life Support (ECLS); Type: ACTIVE_COMPARATOR; Interventions: Device: Extra-Corporal Life Support (ECLS) | Arm Label: Standard treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Extra-Corporal Life Support (ECLS); Assigned to Arm(s): Extra-Corporal Life Support (ECLS)
B: Arm Label: adrenaline; Type: EXPERIMENTAL; Interventions: Drug: adrenaline | Intervention Type: DRUG; Name: adrenaline; Assigned to Arm(s): adrenaline
C: Arm Label: CCPR protocol; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: ECPR protocol; Type: EXPERIMENTAL; Interventions: Procedure: Extracorporeal cardiopulmonary resuscitation (ECPR) | Intervention Type: PROCEDURE; Name: Extracorporeal cardiopulmonary resuscitation (ECPR); Assigned to Arm(s): ECPR protocol
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Device: HeartNet Ventricular Support System | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Optimal Medical/Device Therapy | Intervention Type: DEVICE; Name: HeartNet Ventricular Support System; Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: Optimal Medical/Device Therapy; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimizing Sedentary Behavior Interventions to Affect Acute Physiological
Brief Summary: An emerging body of epidemiological evidence suggests that various forms of sedentary behavior, including TV viewing, occupational sitting, and total daily sitting, may be associated with all-cause and cardiovascular mortality, overweight and obesity, type 2 diabetes, depression and psychological well-being. Importantly, many of these associations were independent of participation in moderate to vigorous intensity physical activity. We propose a pilot study to assess the feasibility, acceptability and preliminary efficacy of two interventions targeting sedentary behavior. Since it is currently unknown what component of sedentary behavior exposure presents the greatest risk to health, we propose separate interventions to reduce overall sedentary time and to promote breaks in sedentary time.


Options:
A: Arm Label: Control condition; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Physical Activity Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: physical activity coaching | Intervention Type: BEHAVIORAL; Name: physical activity coaching; Assigned to Arm(s): Physical Activity Coaching
B: Arm Label: Reduction in sitting time; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Arm Label: Increase in sit-to-stand transitions; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Intervention Type: BEHAVIORAL; Name: Sedentary behavior; Assigned to Arm(s): Increase in sit-to-stand transitions, Reduction in sitting time
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: ALIVE | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ALIVE; Assigned to Arm(s): Intervention
D: Arm Label: Sit-Stand Desk; Type: EXPERIMENTAL; Interventions: Other: Sit-Stand Desk | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-Stand Desk; Assigned to Arm(s): Sit-Stand Desk

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimizing Sedentary Behavior Interventions to Affect Acute Physiological
Brief Summary: An emerging body of epidemiological evidence suggests that various forms of sedentary behavior, including TV viewing, occupational sitting, and total daily sitting, may be associated with all-cause and cardiovascular mortality, overweight and obesity, type 2 diabetes, depression and psychological well-being. Importantly, many of these associations were independent of participation in moderate to vigorous intensity physical activity. We propose a pilot study to assess the feasibility, acceptability and preliminary efficacy of two interventions targeting sedentary behavior. Since it is currently unknown what component of sedentary behavior exposure presents the greatest risk to health, we propose separate interventions to reduce overall sedentary time and to promote breaks in sedentary time.


Options:
A: Arm Label: Sit-Stand Desk; Type: EXPERIMENTAL; Interventions: Other: Sit-Stand Desk | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-Stand Desk; Assigned to Arm(s): Sit-Stand Desk
B: Arm Label: Physical activity treatment group; Type: EXPERIMENTAL; Interventions: Behavioral: Pedal@Work | Arm Label: Wait List Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Pedal@Work Worksite Wellness | Intervention Type: BEHAVIORAL; Name: Pedal@Work Worksite Wellness; Assigned to Arm(s): Wait List Control | Intervention Type: BEHAVIORAL; Name: Pedal@Work; Assigned to Arm(s): Physical activity treatment group
C: Arm Label: Move; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Move | Arm Label: Stand & Move; Type: EXPERIMENTAL; Interventions: Device: Sit-Stand workstation, Behavioral: Move | Intervention Type: DEVICE; Name: Sit-Stand workstation; Assigned to Arm(s): Stand & Move | Intervention Type: BEHAVIORAL; Name: Move; Assigned to Arm(s): Move, Stand & Move
D: Arm Label: Reduction in sitting time; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Arm Label: Increase in sit-to-stand transitions; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Intervention Type: BEHAVIORAL; Name: Sedentary behavior; Assigned to Arm(s): Increase in sit-to-stand transitions, Reduction in sitting time

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease: a Double Blinded RCT
Brief Summary: The purpose of this study is to determine if the prophylactic use of azithromycin will reduce the total number of days when unscheduled treatment is given outside of the home in a clinic, urgent care, emergency room or hospital setting between the respiratory illness season months (October 1-March 31) and subsequent 2 month follow-up (April and May)


Options:
A: Arm Label: azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: azithromycin | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: azithromycin; Assigned to Arm(s): azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
B: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: azithromycin; Type: EXPERIMENTAL; Interventions: Drug: Azithromycin | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): azithromycin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
C: Arm Label: Azithomycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithomycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Azithromycin treatment 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Placebo 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithromycin treatment 1 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate Efficacy and Safety of Finerenone on the Reduction of Cardiovascular Morbidity and Mortality in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease in Addition to Standard of Care.
Brief Summary: The purpose of this study was to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Eplerenone | Arm Label: 2; Type: NO_INTERVENTION; Interventions: Drug: Eplerenone | Intervention Type: DRUG; Name: Eplerenone; Assigned to Arm(s): 1, 2
B: Arm Label: Treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Eplerenone | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Eplerenone; Assigned to Arm(s): Treatment
C: Intervention Type: DRUG; Name: losartan 100 mg orally once daily; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: spironolactone 25 mg orally once daily; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo once orally once daily; Assigned to Arm(s): N/A
D: Arm Label: BAY94-8862; Type: EXPERIMENTAL; Interventions: Drug: Finerenone (BAY94-8862) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Finerenone (BAY94-8862); Assigned to Arm(s): BAY94-8862 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: HIV Point-of-Care Tests in Babies Study (BABY) - Operational Evaluation of HIV Point-of-Care Tests for Very Early Infant HIV Diagnostics in Infants Born to HIV Infected Mothers in Mbeya, Tanzania
Brief Summary: HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, Tanzania.


Options:
A: Arm Label: Alere q HIV-1/2 Detect for point of care infant testing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Alere q HIV-1/2 Detect for point of care infant testing, Behavioral: HIV DNA PCR testing (Standard of Care) | Arm Label: GeneXpert HIV-1 Qual for point of care infant testing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: GeneXpert HIV-1 Qual for point of care infant testing, Behavioral: HIV DNA PCR testing (Standard of Care) | Intervention Type: BEHAVIORAL; Name: Alere q HIV-1/2 Detect for point of care infant testing; Assigned to Arm(s): Alere q HIV-1/2 Detect for point of care infant testing | Intervention Type: BEHAVIORAL; Name: GeneXpert HIV-1 Qual for point of care infant testing; Assigned to Arm(s): GeneXpert HIV-1 Qual for point of care infant testing | Intervention Type: BEHAVIORAL; Name: HIV DNA PCR testing (Standard of Care); Assigned to Arm(s): Alere q HIV-1/2 Detect for point of care infant testing, GeneXpert HIV-1 Qual for point of care infant testing
B: Arm Label: In-vitro Diagnostics; Type: OTHER; Interventions: Other: In-vitro Diagnostics | Intervention Type: OTHER; Name: In-vitro Diagnostics; Assigned to Arm(s): In-vitro Diagnostics
C: Arm Label: Primary Health care clinics; Type: N/A; Interventions: N/A | Arm Label: Pregnant and breast feeding women; Type: N/A; Interventions: N/A
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Device: Alere q | Intervention Type: DEVICE; Name: Alere q; Assigned to Arm(s): Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Antiproteinuric Effects of Liraglutide Treatment in Patients With Type 2 Diabetes and Albuminuria: A Randomised, Placebo-Controlled Trial
Brief Summary: The purpose of the study is to determine the effect of Liraglutide on albuminuria in type 2 diabetes.


Options:
A: Arm Label: Liraglutide; Type: EXPERIMENTAL; Interventions: Drug: Liraglutide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Liraglutide; Assigned to Arm(s): Liraglutide | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
B: N/A
C: Arm Label: BI 10773 low dose; Type: EXPERIMENTAL; Interventions: Drug: BI 10773, Drug: Placebo | Arm Label: BI 10773 high dose; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: BI 10773 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: BI 10773; Assigned to Arm(s): BI 10773 low dose | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): BI 10773 high dose | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: BI 10773; Assigned to Arm(s): BI 10773 high dose | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): BI 10773 low dose
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin, Drug: Metformin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Metformin | Intervention Type: DRUG; Name: Saxagliptin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 1, 2

Answer: A